A tariff tantrum. DeepSeek’s deep impact. The Philadelphia Eagles’ return to the Super Bowl. Investors have seen plenty to put them on edge so far in 2025.

Shares of Viking Therapeutics (VKTX) slid 8% post-market after the biotech company issued its Q4 earnings report and a pipeline update. Read more here.

Eastman Chemical Company (NYSE: NYSE:EMN), a global specialty materials company valued at $11.79 billion, is positioning itself at the forefront of the circular economy transition while navigating a ...

Axon Enterprise, Inc. (NASDAQ:AXON), a leader in public safety technology with a market capitalization of over $50 billion, has been on a remarkable growth trajectory, driven by its expanding product ...

Bio-gene is not the only ASX life sciences play to bring germ warfare to the US military. The maker of Travelan, ...

Meta's shares have surged 11.70% in three months, driven by strong AI investments, particularly in their Meta ads division.

Check out the video below to gain valuable insights into market trends and potential investment opportunities! *Stock prices used were the prices of Dec. 11, 2024. The video was published on Jan ...

IBM’s AI-powered delivery platform, IBM Consulting Advantage, will be deployed to customize the framework for e&’s specific needs. This platform will assist with persona mapping, market ...

We recently published a list of Billionaire Dan Loeb’s Top Stock Picks. In this article, we are going to take a look at where PG&E Corporation ... can outperform the market by imitating the ...

A four-day international conference on vector-borne diseases commenced at Saveetha Medical College in Chennai on Tuesday (January 21, 2025). According to a press release, the conference was ...

FIL:E - The New York Stock Exchange is shown in ... often at the expense of other countries, but most stock indexes in Asia and Europe made only modest moves. In the bond market, U.S. Treasury yields ...

With a severely depressed high-teens P/E multiple and many potential growth drivers that can keep the double-digit percentage sales growth days alive, I’d not back away from ATD stock’s latest ...